Skip to search.
 TSX Up 0.11% TSX Ventures Down 0.30%

More On NGSX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

NeurogesX, Inc. (NGSX)

-Other OTC
0.01 0.00(0.00%) Mar 2, 2:49PM EST
|Pre-Market : 0.28 0.00 (0.00%) 4:13PM EDT - Nasdaq Real Time Price
Prev Close:0.01
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:-4.64838
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.00 - 0.02
Volume:0
Avg Vol (3m):5,677
Market Cap:166.66k
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for NGSX at this time.

Comparison

Symbol% ChgMkt Cap
NGSX 0.00%166.66k
LLYUp 0.35%83.97B
PFEUp 0.72%212.84B
ENDPUp 3.14%5.27B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeurogesX, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel non-opioid, pain management therapies to address unmet medical needs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback